MedPath

Allopurinol

Allopurinol Tablets USP

Approved
Approval ID

1da7d9d4-ed94-4fe6-827a-6f4b3bdce3c3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 8, 2021

Manufacturers
FDA

NCS HealthCare of KY, LLC dba Vangard Labs

DUNS: 050052943

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

allopurinol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0615-8385
Application NumberANDA075798
Product Classification
M
Marketing Category
C73584
G
Generic Name
allopurinol
Product Specifications
Route of AdministrationORAL
Effective DateMarch 8, 2021
FDA Product Classification

INGREDIENTS (6)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
ALLOPURINOLActive
Quantity: 100 mg in 1 1
Code: 63CZ7GJN5I
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Allopurinol - FDA Drug Approval Details